No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of parotid gland
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of parotid gland
- Malignant neoplasm of head and neck
- Malignant neoplasm of lip, oral cavity and pharynx
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2050 | 1026 | 991 |
| Only index persons | 1359 | 731 | 628 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 62.77 | 63.65 | 61.70 |
| Only index persons | 61.65 | 62.03 | 61.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 239 | 116 | 123 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.06 |
| Median age at first event (years) | 62.06 | 59.60 | 64.37 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_PAROTIDGLAND_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_PAROTIDGLAND_EXALLC | 2.194 [1.68, 2.86] | < 0.001 |
| Birth year | 0.997 [0.98, 1.01] | 0.633 |
During the follow-up period (1.1.1998 — 31.12.2019), 221 out of 616 females with C3_PAROTIDGLAND_EXALLC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_PAROTIDGLAND_EXALLC | 2.515 [1.88, 3.37] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.179 |
During the follow-up period (1.1.1998 — 31.12.2019), 251 out of 568 males with C3_PAROTIDGLAND_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_PAROTIDGLAND_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.22% | 0.508% |
| 5 | 1.346% | 3.053% |
| 10 | 3.443% | 8.707% |
| 15 | 6.808% | 15.943% |
| 20 | 11.325% | 26.163% |
Relationships between endpoints
↥Index endpoint: C3_PAROTIDGLAND_EXALLC – Malignant neoplasm of parotid gland
GWS hits: -